Savant Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $47.9M | Buy |
52,081
+3,887
| +8% | +$3.94M | 0.23% | 65 |
|
|
2025
Q4 | $51.8M | Sell |
48,194
-516
| -1% | -$493K | 0.29% | 55 |
|
|
2025
Q3 | $37.2M | Buy |
48,710
+694
| +1% | +$516K | 0.23% | 71 |
|
|
2025
Q2 | $37.4M | Buy |
48,016
+2,326
| +5% | +$1.81M | 0.27% | 59 |
|
|
2025
Q1 | $37.7M | Sell |
45,690
-4,040
| -8% | -$3.36M | 0.32% | 49 |
|
|
2024
Q4 | $38.4M | Sell |
49,730
-3,270
| -6% | -$2.71M | 0.3% | 56 |
|
|
2024
Q3 | $47M | Buy |
53,000
+11,503
| +28% | +$10.3M | 0.39% | 46 |
|
|
2024
Q2 | $37.6M | Sell |
41,497
-1,454
| -3% | -$1.16M | 0.38% | 53 |
|
|
2024
Q1 | $33.4M | Buy |
42,951
+1,301
| +3% | +$926K | 0.38% | 53 |
|
|
2023
Q4 | $24.3M | Sell |
41,650
-954
| -2% | -$557K | 0.31% | 58 |
|
|
2023
Q3 | $22.9M | Sell |
42,604
-992
| -2% | -$511K | 0.34% | 52 |
|
|
2023
Q2 | $20.4M | Buy |
43,596
+3,082
| +8% | +$1.29M | 0.32% | 58 |
|
|
2023
Q1 | $13.9M | Buy |
40,514
+4,423
| +12% | +$1.49M | 0.26% | 70 |
|
|
2022
Q4 | $13.1M | Buy |
36,091
+960
| +3% | +$340K | 0.32% | 48 |
|
|
2022
Q3 | $11.4M | Buy |
35,131
+580
| +2% | +$184K | 0.35% | 46 |
|
|
2022
Q2 | $11.2M | Buy |
34,551
+844
| +3% | +$253K | 0.34% | 46 |
|
|
2022
Q1 | $9.65M | Buy |
33,707
+2,063
| +7% | +$531K | 0.32% | 53 |
|
|
2021
Q4 | $8.74M | Buy |
31,644
+323
| +1% | +$81.9K | 0.28% | 57 |
|
|
2021
Q3 | $7.24M | Buy |
31,321
+19,435
| +164% | +$4.8M | 0.26% | 56 |
|
|
2021
Q2 | $2.73M | Sell |
11,886
-328
| -3% | -$65.9K | 0.11% | 103 |
|
|
2021
Q1 | $2.28M | Buy |
12,214
+119
| +1% | +$23.3K | 0.12% | 110 |
|
|
2020
Q4 | $2.04M | Buy |
12,095
+649
| +6% | +$96.9K | 0.12% | 114 |
|
|
2020
Q3 | $1.69M | Buy |
11,446
+127
| +1% | +$19.7K | 0.12% | 124 |
|
|
2020
Q2 | $1.86M | Buy |
11,319
+826
| +8% | +$127K | 0.14% | 117 |
|
|
2020
Q1 | $1.46M | Buy |
10,493
+1,056
| +11% | +$145K | 0.14% | 123 |
|
|
2019
Q4 | $1.24M | Sell |
9,437
-7
| -0.1% | -$811 | 0.15% | 116 |
|
|
2019
Q3 | $1.06M | Sell |
9,444
-107
| -1% | -$11.9K | 0.15% | 116 |
|
|
2019
Q2 | $1.06M | Sell |
9,551
-542
| -5% | -$63.8K | 0.15% | 116 |
|
|
2019
Q1 | $1.31M | Buy |
10,093
+73
| +0.7% | +$8.88K | 0.25% | 80 |
|
|
2018
Q4 | $1.16M | Buy |
10,020
+2,303
| +30% | +$257K | 0.24% | 81 |
|
|
2018
Q3 | $828K | Buy |
7,717
+143
| +2% | +$14.3K | 0.15% | 117 |
|
|
2018
Q2 | $646K | Sell |
7,574
-60
| -0.8% | -$4.93K | 0.14% | 121 |
|
|
2018
Q1 | $591K | Buy |
7,634
+50
| +0.7% | +$4.03K | 0.12% | 131 |
|
|
2017
Q4 | $641K | Buy |
7,584
+246
| +3% | +$20.9K | 0.13% | 121 |
|
|
2017
Q3 | $628K | Buy |
7,338
+30
| +0.4% | +$2.46K | 0.14% | 113 |
|
|
2017
Q2 | $601K | Sell |
7,308
-217
| -3% | -$17.7K | 0.14% | 115 |
|
|
2017
Q1 | $633K | Buy |
7,525
+736
| +11% | +$59K | 0.16% | 106 |
|
|
2016
Q4 | $499K | Sell |
6,789
-10
| -0.1% | -$745 | 0.13% | 126 |
|
|
2016
Q3 | $546K | Sell |
6,799
-390
| -5% | -$31.2K | 0.15% | 113 |
|
|
2016
Q2 | $566K | Buy |
7,189
+100
| +1% | +$7.53K | 0.16% | 110 |
|
|
2016
Q1 | $510K | Sell |
7,089
-628
| -8% | -$47.5K | 0.15% | 110 |
|
|
2015
Q4 | $650K | Buy |
7,717
+1,830
| +31% | +$152K | 0.2% | 80 |
|
|
2015
Q3 | $493K | Buy |
5,887
+2,007
| +52% | +$169K | 0.18% | 97 |
|
|
2015
Q2 | $324K | Buy |
3,880
+100
| +3% | +$7.62K | 0.11% | 151 |
|
|
2015
Q1 | $275K | Buy |
3,780
+40
| +1% | +$2.85K | 0.1% | 170 |
|
|
2014
Q4 | $258K | Buy |
3,740
+184
| +5% | +$12.4K | 0.1% | 177 |
|
|
2014
Q3 | $231K | Sell |
3,556
-74
| -2% | -$4.68K | 0.1% | 177 |
|
|
2014
Q2 | $226K | Buy |
3,630
+90
| +3% | +$5.37K | 0.1% | 172 |
|
|
2014
Q1 | $208K | Buy |
+3,540
| New | +$198K | 0.1% | 173 |
|
Other funds holding LLY
VCM
VPM
Savant Capital's LLY Position: Q1 2026 in Review
Savant Capital increased its Eli Lilly (LLY) stake by 8.1% in Q1 2026, buying an estimated $3.94M and bringing the position to 52,081 shares worth $47.9M. The position accounts for 0.23% of the portfolio, ranked #65.
Savant Capital first reported a position in LLY in Q1 2014 and has held it in 49 quarters since. The position peaked at $51.8M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Savant Capital held 52,081 shares of Eli Lilly worth $47.9M as of Q1 2026.
- Savant Capital bought 3,887 Eli Lilly shares in Q1 2026, an estimated $3.94M.
- Eli Lilly made up 0.23% of Savant Capital's portfolio in Q1 2026, its #65 holding.
- Savant Capital first reported a position in Eli Lilly in Q1 2014 and has held it in 49 quarters since.
- Savant Capital's Eli Lilly position peaked at $51.8M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Savant Capital's 13F filing for Q1 2026, filed 4 May 2026.